MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617084907 A) filed by Asfalia Biologics on July 10, 2026, for System For Regulating The Expression Of A Transgene Of Interest.
Inventors include Serguera, Che; Mallet, Jacques; and Christen, Yves.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention relates in general to the field of medicine. More particularly, it relates to expression vectors provided with a safety system for transcriptional and post-transcriptional regulation of the expression of a transgene of interest. The invention also relates to the production of these expression vectors and the use thereof for the implementation of safe cellular therapies.
Disclaimer: Curated by HT Syndication.
